Definium Therapeutics, Inc. (DFTX) vs Dianthus Therapeutics, Inc. (DNTH)
Definium Therapeutics, Inc. and Dianthus Therapeutics, Inc. are both Biotechnology companies. Definium Therapeutics, Inc. and Dianthus Therapeutics, Inc. are of similar size ($5.1B and $4.9B). Definium Therapeutics, Inc. has the higher net margin (0.00% vs −10,097.0%) and the higher return on invested capital (0.00% vs −47.7%). Across the 14 metrics below, Dianthus Therapeutics, Inc. leads on 9 and Definium Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | DFTX | DNTH | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (11,441.39%) | 0.00% |
| Net margin | 0.00% | (10,096.95%) | 0.00% |
| Free cash flow margin | 0.00% | (8,177.99%) | 0.00% |
| Return on equity | (64.09%) | (26.07%) | (57.72%) |
| Return on assets | (51.35%) | (24.98%) | (49.22%) |
| Return on invested capital | 0.00% | (47.74%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack